Precipio Signs Exclusive Manufacturing Agreement for IV-Cell™
June 04, 2019 09:10 ET
|
Precipio, Inc.
NEW HAVEN, Conn., June 04, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has entered into an exclusive subcontracting manufacturing...
Precipio Pathology Sales Performance Metrics Demonstrate Substantial Improvement in Q1-2019
May 30, 2019 10:15 ET
|
Precipio, Inc.
NEW HAVEN, Conn., May 30, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today provides shareholders with three of the key pathology performance metrics...
Precipio CEO enrolls in long term stock purchase plan
May 23, 2019 09:55 ET
|
Precipio, Inc.
NEW HAVEN, Conn., May 23, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that, as previously stated, Ilan Danieli, Precipio’s CEO, has enrolled...
Precipio Regains Nasdaq Listing Compliance
May 15, 2019 11:40 ET
|
Precipio, Inc.
NEW HAVEN, Conn., May 15, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that on May 15, 2019 the Company received a letter from Nasdaq informing...
Precipio Conducts IV-Cell™ Validation Trial with a Prominent Laboratory
May 06, 2019 09:20 ET
|
Precipio, Inc.
NEW HAVEN, Conn., May 06, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it is in the process of completing a trial of its Proprietary IV-Cell...
Precipio Successfully Completes Nasdaq Hearing Process
May 03, 2019 09:10 ET
|
Precipio, Inc.
NEW HAVEN, Conn., May 03, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that yesterday, in accordance with established Nasdaq protocol, the company...
Precipio Reminder of Corporate Update Shareholder Call
May 01, 2019 18:06 ET
|
Precipio, Inc.
NEW HAVEN, Conn., May 01, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), will host a conference call on Monday, May 6th, 2019 at 5:00pm Eastern Time to review...
Precipio Signs First Major International Services Contract
April 29, 2019 08:35 ET
|
Precipio, Inc.
NEW HAVEN, Conn., April 29, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) today announced that it has signed a services contract with a health care...
Precipio Takes Final Step towards Regaining Nasdaq Compliance
April 26, 2019 11:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., April 26, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) today announced that it has implemented a 1-for-15 reverse stock split of...
Precipio Launches Global Expansion Strategy
April 24, 2019 09:01 ET
|
Precipio, Inc.
NEW HAVEN, Conn., April 24, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces the launch of Precipio’s global pathology services. The services are...